These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35059394)

  • 1. PINK1 Alleviates Cognitive Impairments
    Jiang XJ; Wu YQ; Ma R; Chang YM; Li LL; Zhu JH; Liu GP; Li G
    Front Cell Dev Biol; 2021; 9():736267. PubMed ID: 35059394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer's disease.
    Wang XJ; Qi L; Cheng YF; Ji XF; Chi TY; Liu P; Zou LB
    Acta Pharmacol Sin; 2022 Aug; 43(8):1916-1927. PubMed ID: 34893682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin.
    Hu Y; Li XC; Wang ZH; Luo Y; Zhang X; Liu XP; Feng Q; Wang Q; Yue Z; Chen Z; Ye K; Wang JZ; Liu GP
    Oncotarget; 2016 Apr; 7(14):17356-68. PubMed ID: 26943044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer's Disease Through NEDD4L Mediated PINK1 Degradation.
    Liu Q; Ling Z; Zhang J; Yu H; Wang Y; Xue Y; Wang C; Zhao J; Cao J; Duan S; Zhao J
    J Alzheimers Dis; 2022; 85(4):1783-1794. PubMed ID: 34958029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clemastine fumarate attenuates tauopathy and meliorates cognition in hTau mice via autophagy enhancement.
    Zhu J; Jiang X; Chang Y; Wu Y; Sun S; Wang C; Zheng S; Wang M; Yao Y; Li G; Ma R
    Int Immunopharmacol; 2023 Oct; 123():110649. PubMed ID: 37494840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.
    Polydoro M; Acker CM; Duff K; Castillo PE; Davies P
    J Neurosci; 2009 Aug; 29(34):10741-9. PubMed ID: 19710325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer's disease animal model.
    Wan HL; Hong XY; Zhao ZH; Li T; Zhang BG; Liu Q; Wang Q; Zhao S; Wang JZ; Shen XF; Liu GP
    Theranostics; 2021; 11(11):5511-5524. PubMed ID: 33859760
    [No Abstract]   [Full Text] [Related]  

  • 10. Marked Mild Cognitive Deficits in Humanized Mouse Model of Alzheimer's-Type Tau Pathology.
    Cho JD; Kim YA; Rafikian EE; Yang M; Santa-Maria I
    Front Behav Neurosci; 2021; 15():634157. PubMed ID: 34093145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
    Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
    Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang Q; Xia Y; Luo H; Huang S; Wang Y; Shentu Y; Mahaman YAR; Huang F; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Wang X
    Front Mol Neurosci; 2018; 11():437. PubMed ID: 30542264
    [No Abstract]   [Full Text] [Related]  

  • 14. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV/CREB signaling.
    Yin Y; Gao D; Wang Y; Wang ZH; Wang X; Ye J; Wu D; Fang L; Pi G; Yang Y; Wang XC; Lu C; Ye K; Wang JZ
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3773-81. PubMed ID: 27298345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological doses of melatonin impede cognitive decline in tau-related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux.
    Luengo E; Buendia I; Fernández-Mendívil C; Trigo-Alonso P; Negredo P; Michalska P; Hernández-García B; Sánchez-Ramos C; Bernal JA; Ikezu T; León R; López MG
    J Pineal Res; 2019 Aug; 67(1):e12578. PubMed ID: 30943316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy.
    Xia L; Pang Y; Li J; Wu B; Du Y; Chen Y; Luo M; Wang Y; Dong Z
    J Alzheimers Dis; 2021; 84(1):239-248. PubMed ID: 34511503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
    Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
    Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    Dengler-Crish CM; Smith MA; Wilson GN
    J Alzheimers Dis; 2017; 55(4):1605-1619. PubMed ID: 27814296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.